Literature DB >> 27708272

Detection of SHOX gene aberrations in routine diagnostic practice and evaluation of phenotype scoring form effectiveness.

Katerina Hirschfeldova1, Martina Florianova1, Vera Kebrdlova1, Marketa Urbanova1, Jitka Stekrova1.   

Abstract

Heterozygous aberrations of SHOX gene have been reported to be responsible for Léri-Weill dyschondrosteosis (LWD) and small portion of idiopathic short stature. The study was established to assess effectiveness of using phenotype 'scoring form' in patients indicated for SHOX gene defect analysis. The submitted study is based on a retrospective group of 352 unrelated patients enrolled as a part of the routine diagnostic practice and analyzed for aberrations affecting the SHOX gene. All participants were scanned for deletion/duplication within the main pseudoautosomal region (PAR1) using the multiplex ligation-dependent probe amplification (MLPA) method. The phenotype 'scoring form' is used in our laboratory practice to preselect patients for subsequent mutation analysis of SHOX gene-coding sequences. The overall detection rate was 11.1% but there was a significant increase in frequency of SHOX gene defect positive with increasing achieved score (P<0.0001). The most frequent aberration was a causal deletion within PAR1. In three probands, MLPA analysis indicated a more complex rearrangement. Madelung deformity or co-occurrence of disproportionate short stature, short forearm and muscular hypertrophy had represented the most potent markers to determine the likelihood of SHOX gene defect detection. We conclude that appliance of phenotype 'scoring form' had saved excessive sample analysis and enabled effective routine diagnostic testing.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27708272     DOI: 10.1038/jhg.2016.117

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  17 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Crossover clustering and rapid decay of linkage disequilibrium in the Xp/Yp pseudoautosomal gene SHOX.

Authors:  Celia A May; Angela C Shone; Luba Kalaydjieva; Antti Sajantila; Alec J Jeffreys
Journal:  Nat Genet       Date:  2002-06-24       Impact factor: 38.330

3.  Transactivation function of an approximately 800-bp evolutionarily conserved sequence at the SHOX 3' region: implication for the downstream enhancer.

Authors:  Maki Fukami; Fumiko Kato; Toshihiro Tajima; Susumu Yokoya; Tsutomu Ogata
Journal:  Am J Hum Genet       Date:  2006-01       Impact factor: 11.025

4.  SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.

Authors:  Alexander A L Jorge; Silvia C Souza; Miriam Y Nishi; Ana E Billerbeck; Débora C C Libório; Chong A Kim; Ivo J P Arnhold; Berenice B Mendonca
Journal:  Clin Endocrinol (Oxf)       Date:  2007-01       Impact factor: 3.478

Review 5.  The functional consequences of intron retention: alternative splicing coupled to NMD as a regulator of gene expression.

Authors:  Ying Ge; Bo T Porse
Journal:  Bioessays       Date:  2013-12-18       Impact factor: 4.345

6.  Analysis of common SHOX gene sequence variants and ~4.9-kb PAR1 deletion in ISS patients.

Authors:  Roman Solc; Katerina Hirschfeldova; Vera Kebrdlova; Alice Baxova
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

7.  Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.

Authors:  Gudrun A Rappold; Maki Fukami; Beate Niesler; Simone Schiller; Walter Zumkeller; Markus Bettendorf; Udo Heinrich; Elpis Vlachopapadoupoulou; Thomas Reinehr; Kazumichi Onigata; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

8.  Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together?

Authors:  Olivia J Veatch; Suzanne E Goldman; Karen W Adkins; Beth A Malow
Journal:  J Nat Sci       Date:  2015

9.  Alternative splicing and nonsense-mediated RNA decay contribute to the regulation of SHOX expression.

Authors:  Claudia Durand; Ralph Roeth; Harsh Dweep; Irena Vlatkovic; Eva Decker; Katja Ute Schneider; Gudrun Rappold
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

10.  Spectrum of phenotypic anomalies in four families with deletion of the SHOX enhancer region.

Authors:  Valentina Gatta; Chiara Palka; Valentina Chiavaroli; Sara Franchi; Giovanni Cannataro; Massimo Savastano; Antonio Raffaele Cotroneo; Francesco Chiarelli; Angelika Mohn; Liborio Stuppia
Journal:  BMC Med Genet       Date:  2014-07-23       Impact factor: 2.103

View more
  1 in total

Review 1.  Skeletal Dysplasias: What Every Bone Health Clinician Needs to Know.

Authors:  Sarah M Nikkel
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.